How to interpret surrogate markers of efficacy in osteoporosis

被引:7
作者
Eastell, R [1 ]
Delmas, PD
机构
[1] Univ Sheffield, Div Clin Sci N, Sheffield, S Yorkshire, England
[2] Univ Lyon 1, INSERM, Unit 403, F-69365 Lyon, France
关键词
D O I
10.1359/JBMR.050217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1261 / 1262
页数:2
相关论文
共 7 条
[1]   Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate [J].
Eastell, R ;
Barton, I ;
Hannon, RA ;
Chines, A ;
Garnero, P ;
Delmas, PD .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) :1051-1056
[2]  
Hochberg MC, 1999, ARTHRITIS RHEUM-US, V42, P1246, DOI 10.1002/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO
[3]  
2-U
[4]   Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents [J].
Hochberg, MC ;
Greenspan, S ;
Wasnich, RD ;
Miller, P ;
Thompson, DE ;
Ross, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1586-1592
[5]   Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib [J].
Mashiba, T ;
Hirano, T ;
Turner, CH ;
Forwood, MR ;
Johnston, CC ;
Burr, DB .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) :613-620
[6]   Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study [J].
Rosen, CJ ;
Hochberg, MC ;
Bonnick, SL ;
McClung, M ;
Miller, P ;
Broy, S ;
Kagan, R ;
Chen, E ;
Petruschke, RA ;
Thompson, DE ;
de Papp, AE .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) :141-151
[7]   Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate [J].
Watts, NB ;
Cooper, C ;
Lindsay, R ;
Eastell, R ;
Manhart, MD ;
Barton, IP ;
van Staa, TP ;
Adachi, JD .
JOURNAL OF CLINICAL DENSITOMETRY, 2004, 7 (03) :255-261